HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Zeillinger Selected Research

diamminedichlorodihydroxyplatinum IV

8/2009Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
1/2009In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert Zeillinger Research Topics

Disease

77Neoplasms (Cancer)
03/2022 - 02/2002
55Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 07/2002
26Breast Neoplasms (Breast Cancer)
05/2020 - 02/2002
14Carcinoma (Carcinomatosis)
01/2016 - 03/2002
13Ovarian Epithelial Carcinoma
12/2021 - 12/2005
11Carcinogenesis
03/2016 - 08/2002
8Residual Neoplasm
01/2020 - 06/2003
7Colorectal Neoplasms (Colorectal Cancer)
10/2017 - 04/2009
6Circulating Neoplastic Cells
01/2020 - 12/2010
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 05/2007
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020 - 01/2009
5Ascites
01/2018 - 01/2013
5Neoplasm Metastasis (Metastasis)
01/2016 - 08/2002
4Endometrial Neoplasms (Endometrial Cancer)
01/2014 - 01/2002
4Vulvar Neoplasms (Vulvar Cancer)
09/2007 - 03/2004
3Fetal Death
03/2005 - 01/2005
2Pleural Effusion (Pleural Effusions)
01/2022 - 01/2016
2Disease Progression
12/2020 - 01/2020
2Peritoneal Neoplasms
01/2018 - 01/2014
2Fibrosis (Cirrhosis)
01/2017 - 01/2015
2Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2011 - 05/2007
2Uterine Cervical Dysplasia
06/2011 - 09/2007
2Adenocarcinoma
03/2011 - 04/2010
2Pancreatic Neoplasms (Pancreatic Cancer)
09/2010 - 01/2004
2Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
05/2005 - 06/2004
2Noninfiltrating Intraductal Carcinoma (DCIS)
04/2004 - 11/2003
1Lung Neoplasms (Lung Cancer)
01/2019

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
09/2020 - 03/2002
18PlatinumIBA
12/2021 - 12/2005
12Biomarkers (Surrogate Marker)IBA
03/2022 - 09/2007
11Messenger RNA (mRNA)IBA
01/2014 - 02/2002
10DNA (Deoxyribonucleic Acid)IBA
12/2021 - 07/2003
10Protein Isoforms (Isoforms)IBA
04/2012 - 02/2002
8Estrogen ReceptorsIBA
12/2015 - 03/2002
7RNA (Ribonucleic Acid)IBA
01/2016 - 05/2002
7Biological ProductsIBA
07/2015 - 06/2003
6Estrogens (Estrogen)FDA Link
01/2018 - 02/2006
6Interleukin-1 (Interleukin 1)IBA
06/2011 - 11/2002
5Pharmaceutical PreparationsIBA
01/2022 - 01/2009
5AntigensIBA
01/2021 - 03/2005
5EnzymesIBA
01/2019 - 03/2006
5Epithelial Cell Adhesion MoleculeIBA
07/2015 - 07/2010
5Progesterone Receptors (Progesterone Receptor)IBA
04/2012 - 03/2002
5ErbB Receptors (EGF Receptor)IBA
12/2011 - 05/2007
5Interleukin-6 (Interleukin 6)IBA
12/2005 - 06/2003
4Codon (Codons)IBA
06/2016 - 12/2005
4ParaffinIBA
02/2013 - 04/2010
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2007 - 07/2002
4Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
07/2006 - 01/2002
4Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2006 - 01/2002
4InterleukinsIBA
08/2005 - 01/2002
3Hormones (Hormone)IBA
06/2017 - 12/2007
3human ERBB2 proteinIBA
06/2016 - 11/2015
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2012 - 11/2002
3Cisplatin (Platino)FDA LinkGeneric
08/2011 - 01/2009
3CytokinesIBA
03/2009 - 03/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2005 - 09/2002
3Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
08/2005 - 11/2002
2Cell-Free Nucleic AcidsIBA
12/2021 - 01/2008
2AnionsIBA
01/2018 - 09/2011
2Peptides (Polypeptides)IBA
01/2018 - 09/2011
2SulfatasesIBA
06/2017 - 01/2013
2Steryl-Sulfatase (Steroid Sulfatase)IBA
06/2017 - 01/2013
2SteroidsIBA
06/2017 - 01/2013
2estrone sulfotransferaseIBA
06/2017 - 01/2013
2Carrier Proteins (Binding Protein)IBA
01/2017 - 01/2013
23' Untranslated Regions (3' UTR)IBA
01/2016 - 04/2008
2Cadherins (E-Cadherin)IBA
01/2016 - 01/2007
2isoleucylvalineIBA
12/2015 - 11/2015
2Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
01/2014 - 03/2005
2Peroxidase (Myeloperoxidase)IBA
01/2014 - 05/2007
2Blood Proteins (Serum Proteins)IBA
04/2013 - 01/2013
2Estrogen Receptor alphaIBA
09/2012 - 02/2006
2Steroid Receptors (Steroid Receptor)IBA
04/2012 - 04/2010
2CollagenIBA
12/2011 - 03/2003
2Paclitaxel (Taxol)FDA LinkGeneric
09/2011 - 06/2009
2C-Reactive ProteinIBA
06/2011 - 02/2008
2diamminedichlorodihydroxyplatinum IVIBA
08/2009 - 01/2009
2AntibodiesIBA
12/2007 - 08/2005
2ChemokinesIBA
12/2007 - 04/2004
2Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
03/2006 - 05/2005
2LigandsIBA
12/2005 - 06/2005
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
06/2005 - 05/2005
1fascaplysineIBA
01/2022
1AfatinibIBA
01/2022
1Transfer RNA (tRNA)IBA
12/2021
1AlbuminsIBA
11/2021
1AutoantibodiesIBA
01/2021
1EpitopesIBA
01/2021
1Kallikreins (Kallikrein)IBA
05/2020
1salinomycinIBA
01/2020
1NiclosamideFDA Link
01/2020
1Peptide Hydrolases (Proteases)FDA Link
01/2019
1CathepsinsIBA
01/2019
1SphingolipidsIBA
01/2019
1Amyloid (Amyloid Fibrils)IBA
11/2018

Therapy/Procedure

21Drug Therapy (Chemotherapy)
01/2022 - 07/2002
20Therapeutics
09/2020 - 11/2002
3Cytoreduction Surgical Procedures
06/2013 - 03/2012
2Microspheres (Microsphere)
07/2010 - 08/2005